CYP2E1 knockout mice |
Chronic ethanol |
Liver injury, oxidative stress, steatosis |
Increased oxidative stress |
Increased steatosis and injury |
[40] |
C57BL/6 mice |
Pyrazole±LPS |
Liver injury and oxidative stress |
MAPK activation |
Increased injury |
[41] |
C57BL/6 mice |
Ethanol±Jo2 antibody |
Liver injury and oxidative stress |
Mitochondrial dysfunction |
Increased injury |
[44] |
JNK1 and JNK2 knockout mice |
Pyrazole±TNF |
Liver injury, oxidative stress, mitochondrial dysfunction |
JNK1 activation |
Decreased injury in jnk1−/− mice |
[45] |
C57BL/6 mice |
Pyrazole±TNF |
Liver injury, oxidative stress, MAPK activation |
ASK-1 activation |
Increased injury |
[41] |
CYP2E1 knockout mice |
Ethanol±Jo2 antibody |
Liver injury, MAPK activation |
Increased death receptor signaling |
increased injury |
[68] |
C57BL/6 mice and CYP2E1 overexpressing HepG2 cells |
Ethanol gavage in mice and ethanol treatment in cells |
Cellular injury, oxidative stress, hepatic steatosis |
Increased autophagy |
Decreased steatosis |
[58] |
CYP2E1 overexpressing HepG2 cells |
siRNA knockdown of thioredoxin |
MAPK activation, cell survival |
ASK-1 and JNK activation |
Increased cell death |
[48] |
CYP2E1 overexpressing HepG2 cells |
3-Methyladenine or Atg 7 siRNA |
Oxidative stress, MAPK activation, cell survival |
Decreased autophagy |
Increased injury |
[57] |